Shown verbatim: the complete text as captured from the official page posted by the Mississippi Legislature, fetched 2026-08-29. This is the enrolled version. The official bill page.
MISSISSIPPI LEGISLATURE
2026 Regular Session
To: Drug Policy
By: Senator(s) Turner-Ford
Senate Bill 2117
(As Sent to Governor)
AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972,
TO INCLUDE 13 SUBSTANCES AS SCHEDULE I CONTROLLED SUBSTANCES BECAUSE THESE
DRUGS HAVE NO LEGITIMATE MEDICAL USE AND HAVE A HIGH POTENCY WITH GREAT
POTENTIAL TO CAUSE HARM; AND FOR RELATED PURPOSES.
BE IT ENACTED BY THE
LEGISLATURE OF THE STATE OF MISSISSIPPI:
SECTION 1. Section
41-29-113, Mississippi Code of 1972, is amended as follows:
41-29-113.
SCHEDULE
I
(a) Schedule I consists of
the drugs and other substances, by whatever official name, common or usual
name, chemical name, or brand name designated, that is listed in this section.
(b) Opiates. Unless
specifically excepted or unless listed in another schedule, any of the
following opiates, including their isomers, esters, ethers, salts and salts of
isomers, esters and ethers, whenever the existence of these isomers, esters,
ethers and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(2) Acetylmethadol;
(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide),
also known as acryloylfentanyl;
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)
cyclohexylmethyl]benzamide);
(6) Allylprodine;
(7)
Alphacetylmethadol, except levo-alphacetylmethadol (levo-alpha-acetylmethadol,
levomethadyl acetate, or LAAM);
(8) Alphameprodine;
(9) Alphamethadol;
(10) Alpha′-methyl
butyryl fentanyl (2-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
(11) Alpha-Methylfentanyl
(N-[1-alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
(12) Alpha-Methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(13) Benzethidine;
(14)
Betacetylmethadol;
(15) Beta-Hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(16) Beta-Hydroxy-3-methylfentanyl
(N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
(17) Beta-Hydroxythiofentanyl
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
(18) Betameprodine;
(19) Betamethadol;
(20) Beta-Methyl
fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide), also
known as β-methyl fentanyl;
(21) Beta-methylacetyl
fentanyl (N-phenyl-N-1-2-phenylpropyl)piperidin-4-yl)acetamide);
( * * *2122) Beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide),
also known as β'-phenyl fentanyl or 3-phenylpropanoyl fentanyl;
( * * *2223) Betaprodine;
( * * *2324) Brorphine (1–(1–(1–(4-bromophenyl)ethyl)piperidin-4–yl)–1,3-dihydro-2H-benzo[d]imidazol-2-one);
(25) Butonitazene
(2-2-4-butoxybenzyl)-5-nitro-1H-benzimidazol1-yl)-N,N-diethylethan-1-amine);
( * * *2426) Butyrl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
( * * *2527) Clonitazene;
( * * *2628) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide);
( * * *2729) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);
( * * *2830) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
( * * *2931) Dextromoramide;
( * * *3032) Diampromide;
( * * *3133) Diethylthiambutene;
( * * *3234) Difenoxin;
( * * *3335) Dimenoxadol;
( * * *3436) Dimepheptanol;
( * * *3537) 2′,5′-dimethoxyfentanyl
(N-1-2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
( * * *3638) Dimethylthiambutene;
( * * *3739) Dioxaphetyl butyrate;
( * * *3840) Dipipanone;
( * * *3941) Ethylmethylthiambutene;
( * * *4042) Etodesnitazene (2-2-4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine,
also known as etazene;
( * * *4143) Etonitazene;
( * * *4244) Etoxeridine;
( * * *4345) Fentanyl carbamate (ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate);
( * * *4446) Fentanyl-related substances,
meaning any substance not otherwise listed under another schedule and for which
no exemption or approval is in effect under Section 505 of the Federal Food,
Drug, and Cosmetic Act [21 USC 355] that is structurally related to fentanyl by
one or more of the following modifications:
(A) Replacement of
the phenyl portion of the phenethyl group by any monocycle, whether or not
further substituted in or on the monocycle;
(B) Substitution
in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo,
haloalkyl, amino or nitro groups;
(C) Substitution
in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether,
hydroxyl, halo, haloalkyl, amino or nitro groups;
(D) Replacement of
the aniline ring with any aromatic monocycle whether or not further substituted
in or on the aromatic monocycle; and/or
(E) Replacement of
the N-propionyl group by another acyl group.
(47) Flunitazene
(N,N-diethyl-2-2-4-fluorobenzyl)-5-nitro-1H-benzimidazol1-yl)ethan-1-amine);
( * * *4548) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide),
also known as para-fluoroisobutyryl fentanyl);
( * * *4649) 2'-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)
propionamide), also known as 2'-fluoro
2-fluorofentanyl;
( * * *4750) Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide);
( * * *4851) 3-furanyl fentanyl (N-1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
( * * *4952) Furethidine;
( * * *5053) Hydroxypethidine;
( * * *5154) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);
( * * *5255) Isotonitazene (N,N-diethyl-2-(2-(4
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
( * * *5356) Isovaleryl fentanyl (3-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
( * * *5457) Ketobemidone (including the
optical and geometric isomers);
( * * *5558) Levomoramide;
( * * *5659) Levophenacylmorphan;
( * * *5760) Meta-fluorofentanyl (N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide);
(61) Meta-fluorofuranyl
fentanyl (N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide);
( * * *5862) Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)isobutyramide);
( * * *5963) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
(64) Metodesnitazene
(N,N-diethyl-2-2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine);
( * * *6065) 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);
( * * *6166) 2-methyl AP–237 (1-2-methyl-4-3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one;
( * * *6267) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
( * * *6368) 3-Methylthiofentanyl (N-[3-methyl-1-
(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide);
( * * *6469) Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide);
( * * *6570) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine
(metonitazene);
( * * *6671) Morpheridine;
( * * *6772) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
( * * *6873) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
( * * *6974) N-pyrrolidino etonitazene 2-4-ethoxybenzyl)-5-nitro-1-2-pyrrolidin-1-yl)ethyl)-1H-benzimidazole,
also known as etonitazepyne;
( * * *7075) Noracymethadol;
( * * *7176) Norlevorphanol;
( * * *7277) Normethadone;
( * * *7378) Norpipanone;
( * * *7479) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-
(1-phenethylpiperidin-4-yl)acetamide);
(80) Ortho-chlorofentanyl
(N-2-chlorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide);
( * * *7581) Ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);
( * * *7682) Ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide),
also known as 2-fluorobutyryl fentanyl;
( * * *7783) Ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide),
also known as 2-fluorofentanyl;
( * * *7884) Ortho-fluorofuranyl fentanyl (N-2-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide);
( * * *7985) Ortho-Fluoroisobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
(86) Ortho-methylcyclopropyl
fentanyl (N-2-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
( * * *8087) Ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide),
also known as 2-methyl acetylfentanyl;
( * * *8188) Ortho-Methyl methoxyacetyl
fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)
acetamide), also known as 2-methyl
methoxyacetyl fentanyl;
(89) Para-chlorofentanyl
(N-4-chlorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide);
( * * *8290) Para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
( * * *8391) Para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
( * * *8492) Para-Fluorofentanyl (N-(4-fluorophenyl)
-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide);
( * * *8593) Para-Fluoro furanyl fentanyl N-(4-fluorophenyl)-N-
(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
(94) Para-fluoro
valeryl fentanyl (N-4-fluorophenyl)-N-1-phenethylpiperidin-4-yl)pentanamide);
( * * *8695) Para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
( * * *8796) Para-methylcyclopropyl fentanyl
(N-4-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
( * * *8897) Para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide),
also known as 4-methylfentanyl);
( * * *8998) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
( * * *9099) Phenadoxone;
( * * *91100) Phenampromide;
( * * *92101) Phenomorphan;
( * * *93102) Phenoperidine;
( * * *94103) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide),
also known as benzoyl fentanyl;
( * * *95104) Piritramide;
( * * *96105) Proheptazine;
( * * *97106) Properidine;
( * * *98107) Propiram;
( * * *99108) Protonitazene N,N-diethyl-2-5-nitro-2-4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine;
( * * *100109) Racemoramide;
( * * *101110) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-
carboxamide);
(111)
Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide);
( * * *102112) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
( * * *103113) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide),
also known as 2-thiofuranyl fentanyl or thiophene fentanyl;
( * * *104114) Tilidine;
( * * *105115) Trimeperidine;
( * * *106116) U-47700, (3,4-dichloro-N-
[2-(dimethylamino)cyclohexyl]-N-methylbenzamide);
( * * *107117) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide).
(c) Opium derivatives.
Unless specifically excepted or unless listed in another schedule, any of the
following opium derivatives, their salts, isomers and salts of isomers,
whenever the existence of these salts, isomers and salts of isomers is possible
within the specific chemical designation:
(1) Acetorphine;
(2)
Acetyldihydrocodeine;
(3) Benzylmorphine;
(4) Codeine
methylbromide;
(5) Codeine-N-Oxide;
(6) Cyprenorphine;
(7) Desomorphine;
(8) Dihydromorphine;
(9) Drotebanol;
(10) Etorphine (except
hydrochloride salt);
(11) Heroin;
(12) Hydromorphinol;
(13) Methyldesorphine;
(14)
Methyldihydromorphine;
(15)
Monoacetylmorphine;
(16) Morphine
methylbromide;
(17) Morphine
methylsulfonate;
(18) Morphine-N-Oxide;
(19) Myrophine;
(20) Nicocodeine;
(21) Nicomorphine;
(22) Normorphine;
(23) Pholcodine;
(24) Thebacon.
(d) Hallucinogenic
substances. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture or preparation which contains any
quantity of the following substances, their salts, isomers (whether optical,
positional, or geometric) and salts of isomers, whenever the existence of these
salts, isomers and salts of isomers is possible within the specific chemical
designation:
(1) Alpha-ethyltryptamine;
(2) 4-bromo-2,5-dimethoxy-amphetamine;
(3) 4-bromo-2,5-dimethoxyphenethylamine;
(4) 2,5-dimethoxyamphetamine;
(5) 2,5-dimethoxy-4-ethylamphetamine
(DOET);
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(2C-T-7);
(7) 4-methoxyamphetamine;
(8) 5-methoxy-3,4-methylenedioxy-amphetamine;
(9) 4-methyl-2,5-dimethoxy-amphetamine;
(10) 3,4-methylenedioxy
amphetamine;
(11) 3,4-methylenedioxymethamphetamine
(MDMA);
(12) 3,4-methylenedioxy-N-ethylamphetamine
(also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl
MDA, MDE, MDEA);
(13) N-hydroxy-3,4-methylenedioxyamphetamine
(also known as N-hydroxy MDA, N-OHMDA, and N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine);
(14) 3,4,5-trimethoxy
amphetamine;
(15) 5-methoxy-N,N-dimethyltryptamine
(5-MeO-DMT);
(16) Alpha-methyltryptamine
(also known as AMT);
(17) Bufotenine;
(18)
Diethyltryptamine;
(19)
Dimethyltryptamine;
(20) 5-methoxy-N,N-diisopropyltryptamine
(5-MeO-DIPT);
(21) Ibogaine;
(22) Lysergic acid
diethylamide (LSD);
(23) (A) Marijuana
(Hemp as defined and regulated under Sections 69-25-201 through 69-25-221 and
Cannabidiol contained in a legend drug product approved by the Federal Food and
Drug Administration or obtained under Section 41-29-136 are exempt under
Schedule I);
(B) Hashish;
(24) Mescaline;
(25) Parahexyl;
(26) Peyote;
(27) N-ethyl-3-piperidyl
benzilate;
(28) N-methyl-3-piperidyl
benzilate;
(29) Psilocybin;
(30) Psilocyn;
(31) Tetrahydrocannabinols,
meaning tetrahydrocannabinols contained in a plant of the genus Cannabis
(cannabis plant), as well as the synthetic equivalents of the substances
contained in the cannabis plant, or in the resinous extractives of such plant,
and/or synthetic substances, derivatives, and their isomers with similar
chemical structure and pharmacological activity to those substances contained
in the plant such as the following:
(A) 1 cis or trans
tetrahydrocannabinol;
(B) 6 cis or trans
tetrahydrocannabinol;
(C) 3,4 cis or
trans tetrahydrocannabinol.
(Since nomenclature of these
substances is not internationally standardized, compounds of these structures,
regardless of atomic positions, are covered.)
("Tetrahydrocannabinols"
excludes dronabinol and nabilone.) For purposes of this paragraph,
tetrahydrocannabinols do not include hemp or hemp products regulated under
Sections 69-25-201 through 69-25-221.
However, the following
products are exempted from control:
(i) THC-containing
industrial products made from cannabis stalks (e.g., paper, rope and clothing);
(ii)
Processed cannabis plant materials used for industrial purposes, such as fiber
retted from cannabis stalks for use in manufacturing textiles or rope;
(iii) Animal
feed mixtures that contain sterilized cannabis seeds and other ingredients (not
derived from the cannabis plant) in a formula designed, marketed and
distributed for nonhuman consumption;
(iv) Personal
care products that contain oil from sterilized cannabis seeds, such as
shampoos, soaps, and body lotions (if the products do not cause THC to enter
the human body);
(v) Hemp as
regulated under Sections 69-25-201 through 69-25-221; and
(vi) Any
product derived from the hemp plant designed for human ingestion and/or
consumption that is approved by the United States Food and Drug Administration;
(32) Phencyclidine;
(33) Ethylamine analog
of phencyclidine (PCE);
(34) Pyrrolidine
analog of phencyclidine (PHP, PCPy);
(35) Thiophene analog
of phencyclidine;
(36) 1-[1-(2-thienyl)cyclohexyl]
pyrrolidine (TCPy);
(37) 4-methylmethcathinone
(mephedrone);
(38) 3,4-methylenedioxypyrovalerone
(MDPV);
(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine
(2C-E);
(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine
(2C-D);
(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine
(2C-C);
(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine
(2C-I); or 2,5-dimethoxy-4-iodophenethylamine;
(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-2);
(44) 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-4);
(45) 2-(2,5-dimethoxyphenyl)ethanamine
(2C-H);
(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine
(2C-N);
(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine
(2C-P);
(48) 3,4-methylenedioxy-N-methylcathinone(methylone);
(49) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36);
(50) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82);
(51) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
or N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5);
(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,
4-benzodiazepin-2-one (also known as Phenazepam);
(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,
11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene (also known as
Etizolam);
(54) Salvia divinorum;
(55) Synthetic
cannabinoids. Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of a synthetic cannabinoid found in any of the following chemical
groups, whether or not substituted to any extent, or any of those groups which
contain any synthetic cannabinoid salts, isomers, or salts of isomers, whenever
the existence of such salts, isomers, or salts of isomers is possible within
the specific chemical designation, including all synthetic cannabinoid chemical
analogues in such groups:
(A) (6aR,10aR)-9-(hydroxymethyl)-6,
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol
(also known as HU-210 or 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol);
(B)
Naphthoylindoles and naphthylmethylindoles, being any compound structurally
derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane,
whether or not substituted in the indole ring to any extent, or in the naphthyl
ring to any extent;
(C)
Naphthoylpyrroles, being any compound structurally derived from 3-(1-naphthoyl)pyrrole,
whether or not substituted in the pyrrole ring to any extent, or in the
naphthyl ring to any extent;
(D)
Naphthylmethylindenes, being any compound structurally derived from 1-(1-naphthylmethyl)indene,
whether or not substituted in the indene ring to any extent or in the naphthyl
ring to any extent;
(E)
Phenylacetylindoles, being any compound structurally derived from 3-phenylacetylindole,
whether or not substituted in the indole ring to any extent or in the phenyl
ring to any extent;
(F)
Cyclohexylphenols, being any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol,
whether or not substituted in the cyclohexyl ring to any extent or in
the phenolic ring to any extent;
(G)
Benzoylindoles, whether or not substituted in the indole ring to any extent or
in the phenyl ring to any extent;
(H)
Adamantoylindoles, whether or not substituted in the indole ring to any extent
or in the adamantoyl ring system to any extent;
(I) Tetrahydro
derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its
tetrahydro derivatives, except where contained in cannabis or cannabis resin;
(J) 3-Cyclopropylmethanone
indole or 3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by
substitution at the nitrogen atom of the indole ring, whether or not further
substituted in the indole ring to any extent, whether or not substituted on the
cyclopropyl, cyclobutyl or cyclopentyl rings to any extent;
(K) Quinolinyl
ester indoles, being any compound structurally derived from 1H-indole-3carboxylic
acid-8-quinolinyl ester, whether or not substituted in the indole ring to any
extent or the quinolone ring to any extent;
(L) 3-carboxamide-1H-indazoles,
whether or not substituted in the indazole ring to any extent and substituted
to any degree on the carboxamide nitrogen and 3-carboxamide-1H-indoles, whether
or not substituted in the indole ring to any extent and substituted to any
degree on the carboxamide nitrogen;
(M)
Cycloalkanemethanone Indoles, whether or not substituted at the nitrogen atom
on the indole ring, whether or not further substituted in the indole ring to
any extent, whether or not substituted on the cycloalkane ring to any extent;
(56) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate,
also known as NM2201 or CBL2201;
(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-
pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 5F-CUMYL-P7AICA or SGT-25;
(58) Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate,
also known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA);
(59) 1-(4-methoxyphenyl)-N-methylpropan-2-amine,
also known as para-methoxymethamphetamine or PMMA;
(60) Ethyl 2-(1-(5-fluoropentyl)
-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, also known as 5F-EDMB-PINACA;
(61) Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate,
also known as 5F-MDMB-PICA or 5F-MDMB-2201;
(62) N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide,
also known as FUB-AKB48 or FUB-APINACA or AKB48 N-(4-fluorobenzyl);
(63) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone,
also known as FUB-144;
(64) N-ethylhexedrone,
also known as α-ethylaminohexanophenone or 2-(ethylamino)-1-phenylhexan-1-one;
(65) Alpha-pyrrolidinohexanophenone,
also known as α-PHP or α-pyrrolidinohexanophenone or 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one);
(66) 4-methyl-alpha-ethylaminopentiophenone,
also known as 4-MEAP or 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one);
(67) 4'-methyl-alpha-pyrrolidinohexiophenone,
also known as MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone or 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one);
(68) Alpha-pyrrolidinoheptaphenone
(also known as PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one);
(69) 4'-chloro-alpha-pyrrolidinovalerophenone,
also known as 4-chloro-α-PVP or 4'-chloro-α-pyrrolidinopentiophenone
or 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one);
(70) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one,
also known as methoxetamine or MXE;
(71) Zipeprol
(1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol);
(72) Eutylone
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one);
and
(73) ADB–BUTINACA
N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide.
(e) Depressants.
Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation which contains any quantity of the
following substances having a depressant effect on the central nervous system,
including their salts, isomers, and salts of isomers, whenever the existence of
such salts, isomers, and salts of isomers is possible within the specific
chemical designation:
(1) Clonazolam,
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
(2) Flualprazolam,
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
(3) Flubromazepam,
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one;
(4) Flubromazolam,
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin;
(5) Gamma-hydroxybutyric
acid (other names include: GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic
acid; sodium oxybate; sodium oxybutyrate);
(6) Mecloqualone;
(7) Methaqualone.
(f) Stimulants. Any
material, compound, mixture or preparation which contains any quantity of the
following central nervous system stimulants including optical salts, isomers
and salts of isomers unless specifically excepted or unless listed in another
schedule:
(1) Aminorex;
(2) Amineptine
(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic
acid);
(3) N-benzylpiperazine
(also known as BZP and 1-benzylpiperazine);
(4) Cathinone;
(5) 4,4'-Dimethylaminorex,
also known as 4,4'-DMAR or 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine;
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine);
(6) Fenethylline;
(7) Mesocarb
(N-phenyl-N' -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-
ium-5-yl)carbamimidate);
(8) Methcathinone;
(9) Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine));
(10) 4-methylaminorex
(also known as 2-amino-4-methyl-5-phenyl-2-oxazoline);
(11) N-ethylamphetamine;
(12) Any material,
compound, mixture or preparation which contains any quantity of N,N-dimethylamphetamine.
(Other names include: N,N,-alpha-trimethyl-benzeneethanamine and N,N-alpha-trimethylphenethylamine);
(13) Synthetic
cathinones. (A) Unless listed in another schedule, any
compound other than bupropion that is structurally derived from 2-Amino-1-phenyl-1-propanone
by modification in any of the following ways:
(i)
By substitution in the phenyl ring to any extent with alkyl, alkoxy,
alkylenedioxy, haloalkyl or halide substituents, whether or not further
substituted in the phenyl ring by one or more other univalent substituents;
(ii)
By substitution at the 3-position with an alkyl substituent;
(iii)
By substitution at the nitrogen atom with alkyl or dialkyl groups, or by
inclusion of the nitrogen atom in a cyclic structure.
(B) The compounds
covered in this paragraph * * * (10) (13) include,
but are not limited to, any material, compound, mixture or preparation which
contains any quantity of a synthetic cathinone found in any of the following
compounds, whether or not substituted to any extent, or any of these compounds
which contain any synthetic cathinone, or salts, isomers, or salts of isomers,
whenever the existence of such salts, isomers or salts of isomers is possible,
unless specifically excepted or listed in another schedule:
(i) 4-methyl-N-ethylcathinone
("4-MEC");
(ii) 4-methyl-alpha-pyrrolidinopropiophenone
("4-MePPP");
(iii) Alpha-pyrrolidinopentiophenone
("α-PVP");
(iv) 1-(1,3-benzodioxol-5-yl)-2-
(methylamino)butan-1-one ("butylone");
(v) 2-(methylamino)-1-phenylpentan-1-one
("pentedrone");
(vi) 1-(1,3-benzodioxol-5-yl)-2-
(methylamino)pentan-1-one ("pentylone");
(vii) 4-fluoro-N-methylcathinone
("4-FMC");
(viii) 3-fluoro-N-methylcathinone
("3-FMC");
(ix) 1-(naphthalen-2-yl)-2-
(pyrrolidin-1-yl) pentan-1-one ("naphyrone");
(x) Alpha-pyrrolidinobutiophenone
("α-PBP");
(xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)
-pentan-1-one (N-ethylpentylone, ephylone);
(xii) 1-1,3-benzodioxol-5-yl)-2-dimethylamino)pentan-1-one
(also known as dipentylone or N,N-dimethylpentylone);
(xiii)
4–CMC, 1-4-chlorophenyl)-2-methylamino)propan-1-one (also known as 4-chloromethcathinone);
(14) a-PiHP
4-methyl-1-phenyl-2-pyrrolidin-1-yl)pentan-1-one,
also known as alpha-PiHP; * * * and
(15) 3–MMC
2-methylamino)-1-3-methylphenyl)propan-1-one,
also known as 3-methylmethcathinone * * *.; and
(16) Ethyl 2-phenyl-2-piperidin-2-yl)acetate)
(also known as Ethylphenidate).
SECTION 2. This act
shall take effect and be in force from and after July 1, 2026.Every fact on this page links to its source, starting with the official bill record.